258 related articles for article (PubMed ID: 10188055)
1. Cancer-testis antigens: targets for cancer immunotherapy.
Chen YT; Old LJ
Cancer J Sci Am; 1999; 5(1):16-7. PubMed ID: 10188055
[No Abstract] [Full Text] [Related]
2. [Adaptive immunotherapy of the advanced prostate cancer - cancer testis antigen (CTA) as possible target antigens].
Prikler L; Scandella E; Men Y; Engeler DS; Diener PA; Gillessen S; Ludewig B; Schmid HP
Aktuelle Urol; 2004 Aug; 35(4):326-30. PubMed ID: 15459874
[TBL] [Abstract][Full Text] [Related]
3. [Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases].
Jäger E; Jäger D; Knuth A
Dtsch Med Wochenschr; 2001 Sep; 126(37):1011-6. PubMed ID: 11555776
[No Abstract] [Full Text] [Related]
4. Cancer immunotherapy targeting the telomerase reverse transcriptase.
Huo LF; Tang JW; Huang JJ; Huang PT; Huang CF; Kung HF; Lin MC
Cell Mol Immunol; 2006 Feb; 3(1):1-11. PubMed ID: 16549043
[TBL] [Abstract][Full Text] [Related]
5. [Tumor antigens].
Tiuriaeva II
Tsitologiia; 2008; 50(3):189-209. PubMed ID: 18664121
[TBL] [Abstract][Full Text] [Related]
6. Cancer vaccines: pessimism in check.
Mocellin S; Mandruzzato S; Bronte V; Marincola FM
Nat Med; 2004 Dec; 10(12):1278-9; author reply 1279-80. PubMed ID: 15580242
[No Abstract] [Full Text] [Related]
7. Immunotherapy of surgical malignancies.
Morse MA; Lyerly HK; Clay TM; Abdel-Wahab O; Chui SY; Garst J; Gollob J; Grossi PM; Kalady M; Mosca PJ; Onaitis M; Sampson JH; Seigler HF; Toloza EM; Tyler D; Vieweg J; Yang Y
Curr Probl Surg; 2004 Jan; 41(1):15-132. PubMed ID: 14749625
[No Abstract] [Full Text] [Related]
8. Tumor immunology at the service of cancer immunotherapy.
Finn OJ
Curr Opin Immunol; 2004 Apr; 16(2):127-9. PubMed ID: 15023402
[No Abstract] [Full Text] [Related]
9. Tumor antigens as surrogate markers and targets for therapy and vaccines.
Dalgleish A; Pandha H
Adv Cancer Res; 2007; 96():175-90. PubMed ID: 17161680
[TBL] [Abstract][Full Text] [Related]
10. T-cell epitope peptide vaccines.
Elsawa SF; Rodeberg DA; Celis E
Expert Rev Vaccines; 2004 Oct; 3(5):563-75. PubMed ID: 15485336
[TBL] [Abstract][Full Text] [Related]
11. The potential of melanoma antigen expression in cancer therapy.
Gillespie AM; Coleman RE
Cancer Treat Rev; 1999 Aug; 25(4):219-27. PubMed ID: 10448130
[TBL] [Abstract][Full Text] [Related]
12. Expression, purification and characterization of the cancer-germline antigen GAGE12I: a candidate for cancer immunotherapy.
Gjerstorff MF; Besir H; Larsen MR; Ditzel HJ
Protein Expr Purif; 2010 Oct; 73(2):217-22. PubMed ID: 20546897
[TBL] [Abstract][Full Text] [Related]
13. Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients.
Valmori D; Dutoit V; Liénard D; Rimoldi D; Pittet MJ; Champagne P; Ellefsen K; Sahin U; Speiser D; Lejeune F; Cerottini JC; Romero P
Cancer Res; 2000 Aug; 60(16):4499-506. PubMed ID: 10969798
[TBL] [Abstract][Full Text] [Related]
14. [Oncoimmunology: some fundamental problems of cancer immunotherapy].
Nedospasov SA; Kuprash DV
Mol Biol (Mosk); 2007; 41(2):355-68. PubMed ID: 17514902
[TBL] [Abstract][Full Text] [Related]
15. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
Jäger D; Jäger E; Bert F; Knuth A
Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
[No Abstract] [Full Text] [Related]
16. How much help does a vaccine-induced T-cell response need?
Weber JS; Mulé JJ
J Clin Invest; 2001 Mar; 107(5):553-4. PubMed ID: 11238555
[No Abstract] [Full Text] [Related]
17. The identification of cancer antigens: impact on the development of cancer vaccines.
Rosenberg SA
Cancer J; 2000 Apr; 6 Suppl 2():S142-9. PubMed ID: 10803829
[No Abstract] [Full Text] [Related]
18. Challenges for cancer vaccine development.
Tabi Z; Man S
Adv Drug Deliv Rev; 2006 Oct; 58(8):902-15. PubMed ID: 16979786
[TBL] [Abstract][Full Text] [Related]
19. Antigens for cancer immunotherapy.
Neller MA; López JA; Schmidt CW
Semin Immunol; 2008 Oct; 20(5):286-95. PubMed ID: 18951039
[TBL] [Abstract][Full Text] [Related]
20. Infrequent and low expression of cancer-testis antigens located on the X chromosome in colorectal cancer: implications for immunotherapy in South African populations.
Dakshinamurthy AG; Ramesar R; Goldberg P; Blackburn JM
Biotechnol J; 2008 Nov; 3(11):1417-23. PubMed ID: 18956367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
